Structure Therapeutics Inc.

1. 01

   Set a 52-week low on 4 Nov 2026

   Closed at $20.36 on 4 Nov 2026: 78.5% below the 52-week high of $94.77 (20 Jan 2026) and 2.1% above the low of $19.94 (4 Nov 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: −25.9% (SPY −1.6%, XLV +13.5%). 3 months: −59.7% (SPY −0.4%, XLV +15.5%). 1 year: −40.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: GPCR, SPY and XLV · as of 4 Nov 2026

3. 03

   Short interest at 10.3% of shares outstanding

   7.1M shares were sold short at the 15 Oct 2026 settlement, 10.3% of the 69.6M shares outstanding; covering them would take 4.8 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $20.36 was 35.8% below its 50-day average ($31.70) and 57.6% below its 200-day average ($48.04). It has closed below the 200-day for 54 sessions, since 20 Aug 2026. The 50-day average crossed below the 200-day on 26 May 2026, 113 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

5. 05

   RSI(14) at 22.7, 30 or below

   The 14-session relative strength index closed at 22.7 on 4 Nov 2026, its 31st session at 30 or below. By convention a reading of 30 or below is called oversold and 70 or above overbought.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

At the 4 Nov 2026 close